Charles W. Lynde

Sep 6, 2024 | onlinelibrary.wiley.com | Vimal H. Prajapati |Charles W. Lynde |Melinda Gooderham |Lynde Dermatology

Why was the study undertaken? Generalized pustular psoriasis (GPP) is a rare, chronic, multisystem, autoinflammatory disease. The clinical course of GPP is highly variable, which can make diagnosis challenging. What does this study add? Clear definition and diagnostic criteria for GPP are essential for effective treatment. This manuscript aims to provide continuity and accuracy in GPP definitions and diagnostic criteria.

Aug 21, 2024 | jamanetwork.com | April Armstrong |Melinda Gooderham |Charles W. Lynde |Catherine Maari

Key PointsQuestion  Is zasocitinib effective and sufficiently safe for treating psoriasis?

Jul 17, 2024 | jamanetwork.com | Andrew Blauvelt |Emma Guttman-Yassky |Charles W. Lynde |Joel Schlessinger

Key PointsQuestion  Is cendakimab efficacious and safe in patients with moderate to severe atopic dermatitis (AD)? Findings  In this randomized clinical trial of 221 patients with moderate to severe AD, treatment with cendakimab was efficacious after 16 weeks, demonstrating improvements in skin clearance, pruritus, and the extent and severity of AD compared with placebo. Cendakimab was generally safe and well-tolerated.

Apr 25, 2023 | dialnet.unirioja.es | Andrew Blauvelt |Emma Guttman-Yassky |Charles W. Lynde |Saakshi Khattri

Ayuda Buscar en la ayuda Buscar en la ayuda Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial Autores: Andrew Blauvelt, Emma Guttman-Yassky, Charles W. Lynde, Saakshi Khattri, Joel Schlessinger, Shinichi Imafuku, Yayoi Tada, Akimichi Morita, Marni Wiseman, Bartlomiej Kwiek, Martina Machkova, Peijin Zhang, Misti Linaberry, Jie Li, Sandra Zhang, Giovanni Franchin, Edgar D.